Advocacy Actions
Comments to the CMDE’s 'Technical Guideline on Examining the Function of Qualitative Testing Reagents (Draft for Public Consultation)'
On 25th September, the Center for Medical Device Evaluation initiated the public consultation on the Technical Guideline on Examining the Function of Qualitative Testing Reagents (Draft for Public Consultation).
Read moreMeeting with ETSI representatives
On 16th October, representatives from the Standards and Conformity Assessment, Healthcare Equipment and Information and Communication Technology Working Groups met with a delegation from the European Telecommunications Standards Institute (ETSI).
Read moreAdvocacy Letter to the Ministry of Finance and the Ministry of Commerce on Buy China Issues
On 15th October, the medical device sector sent two advocacy letter to the Ministry of Finance and the Ministry of Commerce on Buy China issue.
Read moreComments to the CMDE's Public Consultation on the Technical Review Guideline for Quantitative Testing Reagent Performance Assessment Registration
On 10th October, the medical devices sector submitted comments to the Centre for Medical Device Evaluation's (CMDE) Public Consultation on the Technical Reneview Guideline for Quantitative Testing Reagent Performance Assessment Registration.
Read moreEuropean Chamber Healthcare Equipment Working Group Rep. Presents “Buy China” policy issue at the EU Delegation to China
European Chamber Healthcare Equipment Working Group Rep. Presents “Buy China” policy issue at the EU Delegation to China
Read moreMeeting with the Centre for Medical Device Evaluation on the Technical Guideline of Methodological Comparison Techniques for In Vitro Diagnostic Reagent Exempted from Clinical Trials
On 9th October, the Centre for Medical Device Evaluation held a meeting on the Technical Guideline of Methodological Comparison Techniques for In Vitro Diagnostic Reagent Exempted from Clinical Trials.
Read moreComments to the Centre for Medical Device Evaluation on Further Specification of the Clinical Evaluation Section of eRPS
On 30th September, the medical devices sector submitted comments to the Centre for Medical Device Evaluation on further specification of the Clinical Evaluation Section of eRPS.
Advocacy Letter to the Healthcare Security Administration of Jiangsu Province on 'Volume-Based Procurement'
The Healthcare Equipment (HCE) Working Group sent an advocacy letter to the Healthcare Security Administration (HSA) of Jiangsu Province, asking to postpone the second round of 'volume-based procurement' of high-value consumable medical devices.
Read moreComments to the NMPA's Notice on Matters Related to the First Batch of Implementation of the Unique Device Identification of Medical Devices (Call for Comment)
On 25th September, the medical devices sector submitted comments to the National Medical Products Administration on the Notice on Matters Related to the First Batch of Implementation of the Unique Device Identification of Medical Devices (Call for Comment).
Read moreChinese-German Dialogue on Quality Infrastructure in the Field of Medical Devices
The Healthcare Equipment (HCE) Working Group participated in the Chinese-German Dialogue on Quality Infrastructure in the field of medical devices, co-organised by the German Federal Ministry for Economic Affairs and Energy (BMWi) and the Chinese National Medical Products Administration (NMPA).
Read more